Moreover, in the context of PD, the pathological α-synuclein protein has been reported to activate TLRs (Beraud and Maguire-Zeiss, 2012) and it will be of interest to determine if TLR activation results in increased LRRK2 activity. Here, LRRK2 is linked to Parkinson disease.